SWIXX BIOPHARMA EXPANDS TO LATIN AMERICA THROUGH A STRATEGIC ACQUISITION AND COMBINATION WITH BIOPAS
With the addition of $220 million in sales, over 300 employees and therapeutic coverage in Neurology, Oncology, Immunology, Gastroenterology, Rare Diseases and Specialty, acquisition extends & transforms Swixx BioPharma's footprint The acquisition is immediately accretive and creates a...
With the addition of $220 million in sales, over 300 employees and therapeutic coverage in Neurology, Oncology, Immunology, Gastroenterology, Rare Diseases and Specialty, acquisition extends & transforms Swixx BioPharma's footprint The acquisition is immediately accretive and creates a...
